References
- MALTA, E., MAIN, M. A., and RAPER, C., 1985, The in vivo pharmacology of xamoterol (ICI 118,587). British Journal of Pharmacology, 85, 179–187.
- MARTEN, T. R., BOURNE, G. R., MILES, G. D., SHUCKER, B., RAKINE, H. D., and DUTKA, V. N., 1984, The metabolism of ICI 118,587, a partial agonist of firadrenoceptors, in mice, rats, rabbits, dogs, and humans. Drug Metabolism and Disposition, 12, 652–660.
- MEIJER, D. K. F., KEULEMANS, K., and MULDER, G. J., 1981, The isolated perfused rat liver technique. In Methods in Enzymology, edited by W. B. Jakoby (London, Academic Press), vol. 77, pp. 81–93.
- MULDER, G. J., 1981, Sulfation in vivo and in isolated intact cell preparations. In Sulfation of Drugs and Related Compounds, edited by G. J. Mulder (Boca Raton, FL: CRC), pp. 131–186.
- MULDER, G. J., 1984, Sulfation—metabolic aspects. In Progress in Drug Metabolism, edited by J. W. Bridges and L. F. Chasseaud (London: Taylor 8c Francis), vol. 8, pp. 35–100.
- MULDER, G. J., SCHOLTENS, E., and MEIJER, D. K. F., 1981, Collection of metabolites in urine and bile in the rat in vivo. In Methods in Enzymology, edited by W. B. Jakoby (New York: Academic Press), vol. 77, pp. 21–30.
- NUTTAL, A., and SNOW, H. M., 1982, The cardiovascular effects of ICI 118,587: a #1-adrenoceptor partial agonist. British Journal of Pharmacology, 77, 381–388.